関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
バクテリアの遺伝子毒素の組成と機能
Dragana Nesić1, Yun Hsu, C Erec Stebbins
1Laboratory of Structural Microbiology, The Rockefeller University, New York 10021, USA.
Nature
|May 28, 2004
まとめ
サイトレタル・ディステンディング・トキシン (CDT) ホロトキシン構造は,その遺伝子毒性メカニズムを明らかにします. そのDNase-I酵素とリシンのようなレクチンドメインは,特定の相互作用とともに,DNA損傷と宿主細胞の毒性にとって重要である.
科学分野:
- 微生物学 微生物学とは
- 構造生物学 構造生物学とは
- 毒理学 毒理学 毒理学
背景:
- 細胞滅菌毒素 (Cytolethal distending toxin,CDT) は,細胞サイクル停止とアポトーシスを引き起こす三重毒素である.
- CDTのヌクレアースサブユニットであるCdtBは,宿主細胞に転移してDNA損傷を引き起こす.
研究 の 目的:
- Haemophilus ducreyi CDTホロトキシンの結晶構造を解明するために.
- CDTの遺伝子毒性活動と宿主細胞の相互作用にとって重要な構造的特徴を特定する.
主な方法:
- ホロトキシン構造を決定するX線結晶学.
- DNA結合と遺伝子毒性を評価するための生化学分析.
主要な成果:
- ホロトキシンには,DNase-Iファミリー酵素 (CdtB) と2つのリシン型レクチン領域 (CdtA,CdtC) が含まれています.
- 複雑な形成には,相互依存する球状と非球状のインターフェースが含まれます.
- レクチンのサブユニットとCdtCによるステリックブロックの芳香表面は,毒性にとって重要である.
- 遺伝子毒性のために不可欠なCdtBの推定DNA結合残留物が特定されました.
結論:
- 決定された構造は,CDTの遺伝子毒性メカニズムのための分子基盤を提供します.
- 構造的な洞察は,毒素の活性に責任を負う重要な相互作用とドメインを強調します.
- この研究は,細菌の毒素機能と潜在的な治療戦略の理解を容易にする.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K